Samples Quality Improved Using Low-Vacuum Tubes
By LabMedica International staff writers Posted on 16 Jul 2019 |

Image: The BD Barricor tube is a single-use, plastic evacuated tube with a mechanical separator used to collect, separate, transport and process venous blood specimens (Photo courtesy of Becton, Dickinson and Company).
Centrifugation is a time consuming step, which contributes to increase the turnaround time (TAT) in laboratories, likewise hemolyzed samples that needs a re-sampling could delay management of patients.
So, the absence of hemolysis is one of the most important quality indicators for biochemistry as many analytes are influenced at the up or at the down with sample hemolysis. The hemolysis index is a measurement of the red color of serum. This color is normally due almost exclusively to the presence of hemoglobin, which comes from ruptured red blood cell membranes.
Medical biochemists and their colleagues at the Lapeyronie University Hospital (Montpellier, France) evaluated the impact of replacing BD vacutainer heparin lithium tube by low-vacuum BD Vacutainer Barricor tube in an emergency department (ED) on hemolysis rate and TAT. In the first phase blood tests for biochemistry were all performed using 4 mL plastic BD Vacutainer lithium heparin tubes and tubes were then centrifuged during 15 minutes at 2,000g in an emergency dedicated Multifuge X3 FR Centrifuge.
After this first period, all 4 mL BD Vacutainer lithium heparin tubes were removed from the ED and replaced by 3.5 mL BD Vacutainer Barricor lithium heparin tubes during the one day of transition. Hemolysis Index (HI) was measured in the conventional unit (free hemoglobin mg/dL) on all tubes using the Cobas 8000 Roche test SSI-2 on a c701 module. Eight chemistry analytes were measured on the four different Cobas 8000 modules.
The scientists reported that a significantly reduced time duration between reception of sample and available results in informatics laboratory system was observed with the reduction time of centrifugation allowed by use of Barricor tube compared to regular heparin lithium tubes. A statistical significant decrease in hemolysis rate also occurred in the second period as samples with HI less than 10 reached from 52.5% in the first period to 68.5% in the second.
The authors concluded that their study highlighted two advantages when using low-vacuum Barricor tubes which was a reduction of centrifugation time allowing improvement of laboratory TAT and a reduction of hemolyzed samples that improve sample and result quality. The study was published on June 12, 2019, in the journal Practical Laboratory Medicine.
Related Links:
Lapeyronie University Hospital
So, the absence of hemolysis is one of the most important quality indicators for biochemistry as many analytes are influenced at the up or at the down with sample hemolysis. The hemolysis index is a measurement of the red color of serum. This color is normally due almost exclusively to the presence of hemoglobin, which comes from ruptured red blood cell membranes.
Medical biochemists and their colleagues at the Lapeyronie University Hospital (Montpellier, France) evaluated the impact of replacing BD vacutainer heparin lithium tube by low-vacuum BD Vacutainer Barricor tube in an emergency department (ED) on hemolysis rate and TAT. In the first phase blood tests for biochemistry were all performed using 4 mL plastic BD Vacutainer lithium heparin tubes and tubes were then centrifuged during 15 minutes at 2,000g in an emergency dedicated Multifuge X3 FR Centrifuge.
After this first period, all 4 mL BD Vacutainer lithium heparin tubes were removed from the ED and replaced by 3.5 mL BD Vacutainer Barricor lithium heparin tubes during the one day of transition. Hemolysis Index (HI) was measured in the conventional unit (free hemoglobin mg/dL) on all tubes using the Cobas 8000 Roche test SSI-2 on a c701 module. Eight chemistry analytes were measured on the four different Cobas 8000 modules.
The scientists reported that a significantly reduced time duration between reception of sample and available results in informatics laboratory system was observed with the reduction time of centrifugation allowed by use of Barricor tube compared to regular heparin lithium tubes. A statistical significant decrease in hemolysis rate also occurred in the second period as samples with HI less than 10 reached from 52.5% in the first period to 68.5% in the second.
The authors concluded that their study highlighted two advantages when using low-vacuum Barricor tubes which was a reduction of centrifugation time allowing improvement of laboratory TAT and a reduction of hemolyzed samples that improve sample and result quality. The study was published on June 12, 2019, in the journal Practical Laboratory Medicine.
Related Links:
Lapeyronie University Hospital
Latest Clinical Chem. News
- Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
- Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
- AI-Powered Raman Spectroscopy Method Enables Rapid Drug Detection in Blood
- Novel LC-MS/MS Assay Detects Low Creatinine in Sweat and Saliva
- Biosensing Technology Breakthrough Paves Way for New Methods of Early Disease Detection
- New Saliva Test Rapidly Identifies Paracetamol Overdose
- POC Saliva Testing Device Predicts Heart Failure in 15 Minutes
- Screening Tool Detects Multiple Health Conditions from Single Blood Drop
- Integrated Chemistry and Immunoassay Analyzer with Extensive Assay Menu Offers Flexibility, Scalability and Data Commutability
- Rapid Drug Test to Improve Treatment for Patients Presenting to Hospital
- AI Model Detects Cancer at Lightning Speed through Sugar Analyses
- First-Ever Blood-Powered Chip Offers Real-Time Health Monitoring
- New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections
- 3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
- POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
- Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
Channels
Molecular Diagnostics
view channel
RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms
Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more
First Of Its Kind Test Uses microRNAs to Predict Toxicity from Cancer Therapy
Many men with early-stage prostate cancer receive stereotactic body radiotherapy (SBRT), a highly precise form of radiation treatment that is completed in just five sessions. Compared to traditional radiation,... Read more
Novel Cell-Based Assay Provides Sensitive and Specific Autoantibody Detection in Demyelination
Anti-myelin-associated glycoprotein (MAG) antibodies serve as markers for an autoimmune demyelinating disorder that affects the peripheral nervous system, leading to sensory impairment. Anti-MAG-IgM antibodies... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Deliver Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Advanced Imaging Reveals Mechanisms Causing Autoimmune Disease
Myasthenia gravis, an autoimmune disease, leads to muscle weakness that can affect a range of muscles, including those needed for basic actions like blinking, smiling, or moving. Researchers have long... Read more
AI Model Effectively Predicts Patient Outcomes in Common Lung Cancer Type
Lung adenocarcinoma, the most common form of non-small cell lung cancer (NSCLC), typically adopts one of six distinct growth patterns, often combining multiple patterns within a single tumor.... Read moreTechnology
view channel
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more